Leptin is suggested to be an independent predictor of future cardiovascular events, and patients with lower adiponectin levels are at risk of coronary heart disease, type 2 diabetes, hypertension, and dyslipidemia [39,40]. This evidence concerns the gene ADIPOQ and Hypertension.